High-dose therapy and autologous stem cell transplantation (ASCT) for systemic AL amyloidosis (AL): A report on 16 cases.

被引：0
|
作者：
Moreau, P [1 ]
Facon, T [1 ]
Leblond, V [1 ]
Attal, M [1 ]
Caillot, D [1 ]
Nedellec, G [1 ]
Huynh, A [1 ]
Bataille, R [1 ]
Harousseau, JL [1 ]
机构：
[1] DEPT HEMATOL,NANTES,FRANCE
来源：
EXPERIMENTAL HEMATOLOGY | 1997年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [21] Deferred autologous stem cell transplantation in systemic AL amyloidosis
    Richa Manwani
    Ute Hegenbart
    Shameem Mahmood
    Sajitha Sachchithanantham
    Charalampia Kyriakou
    Kwee Yong
    Rakesh Popat
    Neil Rabin
    Carol Whelan
    Tobias Dittrich
    Christoph Kimmich
    Philip Hawkins
    Stefan Schönland
    Ashutosh Wechalekar
    Blood Cancer Journal, 8
  • [22] High-dose chemotherapy with autologous stem cell transplantation in systemic AL amyloidosis: A single centre experience of 20 patients.
    Amoura, Z
    Costedoat, N
    Azar, N
    Montalescot, G
    De Zuttere, D
    Mercadal, L
    Cacoub, P
    Leblond, V
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S122 - S122
  • [23] High Dose Melphalan and Autologous Stem Cell Transplantation for Systemic AL Amyloidosis - Single Institute Analysis of 35 Cases-
    Tsukada, Nobuhiro
    Miyazaki, Kanji
    Abe, Yu
    Sekine, Rieko
    Nakagawa, Yasunori
    Suzuki, Kenshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S191 - S191
  • [24] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    J B Perz
    A Rahemtulla
    C Giles
    R M Szydlo
    J Davis
    D Gopaul
    J Gillmore
    C J Mathias
    P N Hawkins
    J F Apperley
    Bone Marrow Transplantation, 2006, 37 : 937 - 943
  • [25] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    Perz, JB
    Rahemtulla, A
    Giles, C
    Szydlo, RM
    Davis, J
    Gopaul, D
    Gillmore, J
    Mathias, CJ
    Hawkins, PN
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 937 - 943
  • [26] Autologous stem cell transplantation (ASCT) in symptomatic cardiac AL amyloidosis:: A report on 6 patients (pts).
    Sterkers, Y
    Azar, N
    Dhédin, N
    Similowski, T
    Amoura, Z
    Montalescot, G
    Vernant, JP
    Piette, JC
    Leblond, V
    Binet, JL
    BLOOD, 1999, 94 (10) : 575A - 575A
  • [27] Autologous stem cell transplantation (ASCT) in primary systemic amyloidosis (AL): The impact of selection criteria on outcome.
    Mollee, PN
    Wechalekar, AD
    Pereira, DL
    Franke, N
    Reece, D
    Chen, C
    Stewart, AK
    BLOOD, 2002, 100 (11) : 435A - 435A
  • [28] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    P Moreau
    Leukemia, 1999, 13 : 1929 - 1931
  • [29] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    Moreau, P
    LEUKEMIA, 1999, 13 (12) : 1929 - 1931
  • [30] Amyloidosis - Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis
    Hayes-Lattin, BM
    Curtin, PT
    Fleming, WH
    Leis, JF
    Stepan, DE
    Schubach, S
    Maziarz, RT
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 279 - 285
12345